Literature DB >> 8911929

Different effects of visual deprivation on vasoactive intestinal polypeptide (VIP)-containing cells in the retinas of juvenile and adult rats.

H Herbst1, P Thier.   

Abstract

Vasoactive intestinal polypeptide (VIP) is a 28 amino acid peptide that has been shown to be present in a distinct subset of retinal amacrine cells (VIP+ cells). Previous work has suggested that the expression of retinal VIP might depend on the lighting conditions prevailing. Reasoning that a careful analysis of the exact conditions of this interaction and its time course might offer clues to the functional role of retinal VIP, we performed a quantitative immunohistochemical analysis of the effects of visual deprivation on the retinal VIP+ system in adult and in visually inexperienced neonatal rats. In adult rats visual deprivation caused a marked suppression of VIP-like immunoreactivity (IR) in both somata and processes of VIP+ cells which increased linearly over time, reducing the number of VIP+ cells to about 30% of the control value after approximately 50 days of deprivation. The observed changes were specific for VIP and were independent of the form of deprivation used (monocular lid suture versus keeping rats in constant darkness). However, the effects of visual deprivation were dependent on the developmental state of the rats, since juvenile rats without previous visual experience exhibited a decrease in VIP+ cells and fibers which was much smaller and occurred significantly slower than in adult rats. The suppression of VIP-like IR was completely reversible in both juvenile and adult rats when previously deprived rats were returned to a normal visual environment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911929     DOI: 10.1007/bf00228724

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  44 in total

1.  Use of azide and hydrogen peroxide as an inhibitor for endogenous peroxidase in the immunoperoxidase method.

Authors:  C Y Li; S C Ziesmer; O Lazcano-Villareal
Journal:  J Histochem Cytochem       Date:  1987-12       Impact factor: 2.479

2.  Regional specialization of retinal glial cell membrane.

Authors:  E A Newman
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

3.  Vasoactive intestinal peptide alters membrane potential and cyclic nucleotide levels in retinal horizontal cells.

Authors:  E M Lasater; K J Watling; J E Dowling
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

4.  Myopia and eye enlargement after neonatal lid fusion in monkeys.

Authors:  T N Wiesel; E Raviola
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

5.  Control of extracellular potassium levels by retinal glial cell K+ siphoning.

Authors:  E A Newman; D A Frambach; L L Odette
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

6.  VIP (vasoactive intestinal polypeptide)-immunoreactive neurons in the retina of the rat.

Authors:  I Lorén; K Tornqvist; J Alumets
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

7.  The effects of VIP on cyclic AMP and glycogen levels in vertebrate retina.

Authors:  M Schorderet; P Hof; P J Magistretti
Journal:  Peptides       Date:  1984 Mar-Apr       Impact factor: 3.750

8.  Substance P, vasoactive intestinal polypeptide (VIP) and somatostatin levels in ocular tissue of normal and sensorily denervated rabbit eyes.

Authors:  W G Unger; J M Butler; D F Cole; S R Bloom; G P McGregor
Journal:  Exp Eye Res       Date:  1981-06       Impact factor: 3.467

9.  Somatostatin and VIP neurons in the retina of different species.

Authors:  K Tornqvist; R Uddman; F Sundler; B Ehinger
Journal:  Histochemistry       Date:  1982

10.  Evidence of cell loss from the rat retina during senescence.

Authors:  M L Katz; W G Robison
Journal:  Exp Eye Res       Date:  1986-04       Impact factor: 3.467

View more
  1 in total

1.  Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision.

Authors:  Ute Mathis; Frank Schaeffel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.